Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults
Conditions
- Prevention of Malaria Transmission and Clinical Malaria
Interventions
- BIOLOGICAL: 10µg of R21 with 50µg Matrix-M1
- BIOLOGICAL: 6µg of Pfs230D1-CRM197 + 10µg of R21 with 50µg Matrix-M1 single vial coformulation
- BIOLOGICAL: RABIVAX-S
- BIOLOGICAL: Conjugated Pfs230D1 Vaccine (Pfs230D1-CRM197) For Bedside Mixing
- BIOLOGICAL: R21 Malaria Vaccine (Recombinant) For Bedside Mixing
- BIOLOGICAL: MATRIX-M1 (Adjuvant) For Bedside Mixing
Sponsor
Serum Institute of India Pvt. Ltd.
Collaborators